HC Wainwright & Co. Maintains Buy on Korro Bio, Raises Price Target to $115
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has maintained a Buy rating on Korro Bio and increased the price target from $100 to $115, indicating confidence in the company's future performance.
October 18, 2024 | 11:00 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has maintained a Buy rating on Korro Bio and increased the price target from $100 to $115, suggesting a positive outlook for the company's stock.
The increase in the price target from $100 to $115 by HC Wainwright & Co. reflects a positive sentiment towards Korro Bio's future performance. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100